INTELLIGENCE IN ACTION

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

December 03, 2018

In our latest data brief, we share some jaw-dropping early results from our new Real-Time Prescription Benefit service.

For instance, one prescriber saved their patient $8,032 out of pocket on a single prescription.

In another instance, a patient saved nearly $1,400. In fact, our analysis revealed many instances of patient savings in excess of $1,000.

Actual Patient Savings 

Since its launch last year, our Real-Time Prescription Benefit service has truly taken off at the point of care. In fact, it’s reinventing the health IT adoption curve thanks to prescribers embracing this highly desired technology at an incredible rate, and enabling the Surescripts Network Alliance™ to deliver real savings to patients at the pharmacy.

In addition to these impressive out-of-pocket cost savings, prescribers are also saving massive amounts of time because they are able to choose a drug that doesn’t require a prior authorization. In fact, when prescribing a medication requiring a prior authorization and presented an alternative without a prior authorization, prescribers switched the drug 24 percent of the time—eliminating more than 132,000 hours of potential wait time in one month.

With our Real-Time Prescription Benefit solution, integrated with Electronic Prior Authorization and E-Prescribing, we are answering the call of providers across the country for more actionable patient intelligence. When prescribers and patients can see what a medication will cost, along with a list of therapeutic alternatives, they can choose a more affordable option—including one that doesn’t require a prior authorization. By working together, there is no limit to healthcare’s potential to increase care quality and safety while lowering costs.

Read the news release to see more truly amazing results from Real-Time Prescription Benefit.

Related Articles

May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...
April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Healthcare costs are increasingly prohibitive for too many Americans, and these costs can hit older Americans especially hard. That’s why we applaud the Centers for Medicare & Medicaid Services (CMS) proposed rule on real-time benefit tools (RTBT). Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX